Trial
NCT00693472
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Merck Sharp & Dohme LLC
Collaborators
—
Condition
Akathisia, Drug-Induced
Intervention
Preladenant
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-07